SRx Health Solutions Statistics
Total Valuation
SRXH has a market cap or net worth of $3.86 million. The enterprise value is $11.86 million.
Important Dates
The last earnings date was Friday, February 13, 2026, after market close.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRXH has 27.43 million shares outstanding. The number of shares has increased by 7.10% in one year.
| Current Share Class | 27.43M |
| Shares Outstanding | 27.43M |
| Shares Change (YoY) | +7.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 90.87% |
| Owned by Institutions (%) | 2.44% |
| Float | 2.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | n/a |
| PB Ratio | 1.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 5.97.
| Current Ratio | 0.80 |
| Quick Ratio | 0.68 |
| Debt / Equity | 5.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -337.57% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $849,182 |
| Profits Per Employee | -$4.51M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SRXH has paid $4,000 in taxes.
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 44.67 |
| Average Volume (20 Days) | 37,270,254 |
Short Selling Information
The latest short interest is 503,074, so 1.83% of the outstanding shares have been sold short.
| Short Interest | 503,074 |
| Short Previous Month | 2.08M |
| Short % of Shares Out | 1.83% |
| Short % of Float | 20.09% |
| Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, SRXH had revenue of $9.34 million and -$49.64 million in losses. Loss per share was -$2.10.
| Revenue | 9.34M |
| Gross Profit | 2.58M |
| Operating Income | -11.90M |
| Pretax Income | -17.25M |
| Net Income | -49.64M |
| EBITDA | -12.95M |
| EBIT | -11.90M |
| Loss Per Share | -$2.10 |
Full Income Statement Balance Sheet
The company has $13.06 million in cash and $21.03 million in debt, with a net cash position of -$7.97 million or -$0.29 per share.
| Cash & Cash Equivalents | 13.06M |
| Total Debt | 21.03M |
| Net Cash | -7.97M |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 3.52M |
| Book Value Per Share | -0.11 |
| Working Capital | -4.69M |
Full Balance Sheet Margins
| Gross Margin | 27.62% |
| Operating Margin | -127.35% |
| Pretax Margin | -184.66% |
| Profit Margin | n/a |
| EBITDA Margin | -138.68% |
| EBIT Margin | -127.35% |
| FCF Margin | n/a |